489 related articles for article (PubMed ID: 18052762)
1. Almotriptan: meeting today's needs in acute migraine treatment.
Láinez MJ
Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
[TBL] [Abstract][Full Text] [Related]
2. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.
Lipton RB; Cutrer FM; Goadsby PJ; Ferrari MD; Dodick DW; McCrory D; Liberman JN; Williams P
Curr Med Res Opin; 2005 Mar; 21(3):413-24. PubMed ID: 15811210
[TBL] [Abstract][Full Text] [Related]
3. Almotriptan for the treatment of acute migraine: a review of early intervention trials.
Antonaci F; De Cillis I; Cuzzoni MG; Allena M
Expert Rev Neurother; 2010 Mar; 10(3):351-64. PubMed ID: 20187858
[TBL] [Abstract][Full Text] [Related]
4. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
5. Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).
Cutrer FM; Goadsby PJ; Ferrari MD; Lipton RB; Dodick DW; McCrory D; Williams P
Clin Ther; 2004 Sep; 26(9):1533-45. PubMed ID: 15531016
[TBL] [Abstract][Full Text] [Related]
6. Use of almotriptan in triptan-experienced and triptan-naïve patients.
Pascual J; Diener HC
Curr Med Res Opin; 2007 Oct; 23(10):2433-40. PubMed ID: 17723158
[TBL] [Abstract][Full Text] [Related]
7. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
8. Almotriptan: a review of pharmacology, clinical efficacy, and tolerability.
Von S
Am J Manag Care; 2002 Feb; 8(3 Suppl):S74-9. PubMed ID: 11859907
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
10. Almotriptan in triptan-naïve patients: new evidence of benefits.
Pascual J
Cephalalgia; 2008 Sep; 28 Suppl 2():14-20. PubMed ID: 18715328
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis.
Göbel H
Expert Rev Neurother; 2010 Apr; 10(4):499-506. PubMed ID: 20367203
[TBL] [Abstract][Full Text] [Related]
12. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
Sandrini G; Dahlöf CG; Mathew N; Nappi G
Int J Clin Pract; 2005 Nov; 59(11):1356-65. PubMed ID: 16236092
[TBL] [Abstract][Full Text] [Related]
13. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
[TBL] [Abstract][Full Text] [Related]
14. Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.
Mayo KW; Osterhaus JT
Am J Manag Care; 2002 Feb; 8(3 Suppl):S85-93. PubMed ID: 11859909
[TBL] [Abstract][Full Text] [Related]
15. Almotriptan and zolmitriptan in the acute treatment of migraine.
Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
[TBL] [Abstract][Full Text] [Related]
16. Economic comparison of oral triptans for management of acute migraine: implications for managed care.
Reeder CE; Steadman S; Goldfarb SD
Am J Manag Care; 2002 Feb; 8(3 Suppl):S80-4. PubMed ID: 11859908
[TBL] [Abstract][Full Text] [Related]
17. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
Goadsby PJ
Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G
Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
[TBL] [Abstract][Full Text] [Related]
19. Review of clinical trials using early acute intervention with oral triptans for migraine management.
Dowson AJ; Mathew NT; Pascual J
Int J Clin Pract; 2006 Jun; 60(6):698-706. PubMed ID: 16805756
[TBL] [Abstract][Full Text] [Related]
20. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
Sheftell FD; Feleppa M; Tepper SJ; Volcy M; Rapoport AM; Bigal ME
Headache; 2004; 44(7):661-8. PubMed ID: 15209687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]